Vanguard Group’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.86M | Buy |
|
|||||
|
2025
Q1 | $6.7M | Buy |
|
|||||
|
2024
Q4 | $8.26M | Buy |
|
|||||
|
2024
Q3 | $16.1M | Buy |
|
|||||
|
2024
Q2 | $6.09M | Sell |
|
|||||
|
2024
Q1 | $7.4M | Buy |
|
|||||
|
2023
Q4 | $6.61M | Buy |
|
|||||
|
2023
Q3 | $5.09M | Buy |
|
|||||
|
2023
Q2 | $7.15M | Sell |
|
|||||
|
2023
Q1 | $6.34M | Buy |
|
|||||
|
2022
Q4 | $6.49M | Buy |
|
|||||
|
2022
Q3 | $8.69M | Buy |
|
|||||
|
2022
Q2 | $13.7M | Buy |
|
|||||
|
2022
Q1 | $13.1M | Buy |
|
|||||
|
2021
Q4 | $19.3M | Buy |
|
|||||
|
2021
Q3 | $11.7M | Buy |
|
|||||
|
2021
Q2 | $7.3M | Buy |
|
|||||
|
2021
Q1 | $5.37M | Buy |
|
|||||
|
2020
Q4 | $8.18M | Buy |
|